β-Elemene alleviates cisplatin resistance in oral squamous cell carcinoma cell via inhibiting JAK2/STAT3 pathway in vitro and in vivo

β-Elemene suppresses tumor growth of diffuse large B-cell lymphoma through regulating lncRNA HULC-mediated apoptotic pathway

(2020) Tonglin Hu et al.   BIOSCIENCE REPORTS

EGFR Promotes the Development of Triple Negative Breast Cancer Through JAK/STAT3 Signaling

(2020) Xiang Song et al.   Cancer Management and Research

β-elemene suppresses the malignant behavior of esophageal cancer cells by regulating the phosphorylation of AKT

(2020) Yufei Liang et al.   ACTA HISTOCHEMICA

β-Elemene Enhances the Chemotherapeutic Effect of 5-Fluorouracil in Triple-Negative Breast Cancer via PI3K/AKT, RAF-MEK-ErK, and NF-κB Signaling Pathways

(2020) Pengyu Su et al.   OncoTargets and Therapy

β-Elemene Enhances radiosensitivity in non-small-cell lung cancer by inhibiting epithelial–mesenchymal transition and cancer-stewm cell traits via Prx-1/NF-kB/iNOS signaling pathway

(2020) Kun Zou et al.   Aging-US

Chemotherapeutic paclitaxel and cisplatin differentially induce pyroptosis in A549 lung cancer cells via caspase-3/GSDME activation

(2019) Cheng-cheng Zhang et al.   APOPTOSIS

Lung cancer combination therapy: doxorubicin and β-elemene co-loaded, pH-sensitive nanostructured lipid carriers

(2019) Chengsong Cao et al.   Drug Design Development and Therapy

Molecular targets of β-elemene, a herbal extract used in traditional Chinese medicine, and its potential role in cancer therapy: A review

(2019) Bingtao Zhai et al.   BIOMEDICINE & PHARMACOTHERAPY

Cisplatin: The first metal based anticancer drug

(2019) Sumit Ghosh   BIOORGANIC CHEMISTRY

Multi-Targeting by β-Elemene and Its Anticancer Properties: A Good Choice for Oncotherapy and Radiochemotherapy Sensitization

(2019) Hongxuan Tong et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

Cisplatin-Resistance in Oral Squamous Cell Carcinoma: Regulation by Tumor Cell-Derived Extracellular Vesicles

(2019) Xin-Hui Khoo et al.   Cancers

Progress in targeted therapeutic drugs for oral squamous cell carcinoma

(2019) Lian Liu et al.   SURGICAL ONCOLOGY-OXFORD

Cisplatin nephrotoxicity: a review of the literature

(2017) Sandhya Manohar et al.   JOURNAL OF NEPHROLOGY

WITHDRAWN: Elemene Increases Autophagic Apoptosis and Drug Sensitivity in Human Cisplatin (DDP)-Resistant Lung Cancer Cell Line SPC-A-1/DDP By Inducing Beclin-1 Expression

(2017) Kun Zhou et al.   ONCOLOGY RESEARCH

Beta-elemene treatment is associated with improved outcomes of patients with esophageal squamous cell carcinoma

(2017) Zhiwei Chang et al.   SURGICAL ONCOLOGY-OXFORD

Synergistic Cytotoxicity of β-Elemene and Cisplatin in Gingival Squamous Cell Carcinoma by Inhibition of STAT3 Signaling Pathway

(2017) Chengyi Huang et al.   MEDICAL SCIENCE MONITOR

LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression

(2017) Zheng Fang et al.   Cancer Medicine

Interplay of DNA methyltransferase 1 and EZH2 through inactivation of Stat3 contributes to β-elemene-inhibited growth of nasopharyngeal carcinoma cells

(2017) JingJing Wu et al.   Scientific Reports

A novel quantitative immunohistochemistry method for precise protein measurements directly in formalin-fixed, paraffin-embedded specimens: analytical performance measuring HER2

(2016) Kristian Jensen et al.   MODERN PATHOLOGY

Enhancement of cisplatin-induced apoptosis by β-elemene in resistant human ovarian cancer cells

(2012) Qingdi Quentin Li et al.   MEDICAL ONCOLOGY